1. Home
  2. NFE vs VIR Comparison

NFE vs VIR Comparison

Compare NFE & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NFE
  • VIR
  • Stock Information
  • Founded
  • NFE 2014
  • VIR 2016
  • Country
  • NFE United States
  • VIR United States
  • Employees
  • NFE N/A
  • VIR N/A
  • Industry
  • NFE Oil/Gas Transmission
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NFE Utilities
  • VIR Health Care
  • Exchange
  • NFE Nasdaq
  • VIR Nasdaq
  • Market Cap
  • NFE 773.2M
  • VIR 706.4M
  • IPO Year
  • NFE 2019
  • VIR 2019
  • Fundamental
  • Price
  • NFE $2.45
  • VIR $5.27
  • Analyst Decision
  • NFE Strong Buy
  • VIR Strong Buy
  • Analyst Count
  • NFE 6
  • VIR 10
  • Target Price
  • NFE $8.92
  • VIR $26.80
  • AVG Volume (30 Days)
  • NFE 6.5M
  • VIR 1.6M
  • Earning Date
  • NFE 11-06-2025
  • VIR 10-30-2025
  • Dividend Yield
  • NFE N/A
  • VIR N/A
  • EPS Growth
  • NFE N/A
  • VIR N/A
  • EPS
  • NFE N/A
  • VIR N/A
  • Revenue
  • NFE $2,008,012,000.00
  • VIR $19,000,000.00
  • Revenue This Year
  • NFE $7.43
  • VIR N/A
  • Revenue Next Year
  • NFE $8.38
  • VIR $9.65
  • P/E Ratio
  • NFE N/A
  • VIR N/A
  • Revenue Growth
  • NFE N/A
  • VIR N/A
  • 52 Week Low
  • NFE $2.01
  • VIR $4.16
  • 52 Week High
  • NFE $16.66
  • VIR $14.45
  • Technical
  • Relative Strength Index (RSI)
  • NFE 43.46
  • VIR 57.10
  • Support Level
  • NFE $2.23
  • VIR $5.04
  • Resistance Level
  • NFE $2.76
  • VIR $5.64
  • Average True Range (ATR)
  • NFE 0.20
  • VIR 0.32
  • MACD
  • NFE 0.03
  • VIR 0.11
  • Stochastic Oscillator
  • NFE 40.91
  • VIR 64.97

About NFE New Fortress Energy Inc.

New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: